Morphine Sulfate Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Jul 8, 2025.

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1891-23
Dosage Form
Injection
Presentation
Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-23)
Initial Posting
Jul 8, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.